137 related articles for article (PubMed ID: 20435013)
1. Interaction of a new anticancer prodrug, gemcitabine-squalene, with a model membrane: coupled DSC and XRD study.
Pili B; Bourgaux C; Amenitsch H; Keller G; Lepêtre-Mouelhi S; Desmaële D; Couvreur P; Ollivon M
Biochim Biophys Acta; 2010 Aug; 1798(8):1522-32. PubMed ID: 20435013
[TBL] [Abstract][Full Text] [Related]
2. Liposomal squalenoyl-gemcitabine: formulation, characterization and anticancer activity evaluation.
Pili B; Reddy LH; Bourgaux C; Lepêtre-Mouelhi S; Desmaële D; Couvreur P
Nanoscale; 2010 Aug; 2(8):1521-6. PubMed ID: 20820745
[TBL] [Abstract][Full Text] [Related]
3. Interaction of an amphiphilic squalenoyl prodrug of gemcitabine with cellular membranes.
Bildstein L; Pili B; Marsaud V; Wack S; Meneau F; Lepêtre-Mouelhi S; Desmaële D; Bourgaux C; Couvreur P; Dubernet C
Eur J Pharm Biopharm; 2011 Nov; 79(3):612-20. PubMed ID: 21784150
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of gemcitabine affinity for biomembranes by conjugation with squalene: differential scanning calorimetry and Langmuir-Blodgett studies using biomembrane models.
Castelli F; Sarpietro MG; Micieli D; Stella B; Rocco F; Cattel L
J Colloid Interface Sci; 2007 Dec; 316(1):43-52. PubMed ID: 17765257
[TBL] [Abstract][Full Text] [Related]
5. Magnetoresponsive squalenoyl gemcitabine composite nanoparticles for cancer active targeting.
Arias JL; Reddy LH; Couvreur P
Langmuir; 2008 Jul; 24(14):7512-9. PubMed ID: 18540685
[TBL] [Abstract][Full Text] [Related]
6. Gemcitabine-based therapy for pancreatic cancer using the squalenoyl nucleoside monophosphate nanoassemblies.
Maksimenko A; Caron J; Mougin J; Desmaële D; Couvreur P
Int J Pharm; 2015 Mar; 482(1-2):38-46. PubMed ID: 25448549
[TBL] [Abstract][Full Text] [Related]
7. Anticancer efficacy of squalenoyl gemcitabine nanomedicine on 60 human tumor cell panel and on experimental tumor.
Reddy LH; Renoir JM; Marsaud V; Lepetre-Mouelhi S; Desmaële D; Couvreur P
Mol Pharm; 2009; 6(5):1526-35. PubMed ID: 19634915
[TBL] [Abstract][Full Text] [Related]
8. A DSC and FTIR spectroscopic study of the effects of the epimeric 4-cholesten-3-ols and 4-cholesten-3-one on the thermotropic phase behaviour and organization of dipalmitoylphosphatidylcholine bilayer membranes: comparison with their 5-cholesten analogues.
Benesch MG; Mannock DA; Lewis RN; McElhaney RN
Chem Phys Lipids; 2014 Jan; 177():71-90. PubMed ID: 24296232
[TBL] [Abstract][Full Text] [Related]
9. A new nanomedicine of gemcitabine displays enhanced anticancer activity in sensitive and resistant leukemia types.
Reddy LH; Dubernet C; Mouelhi SL; Marque PE; Desmaele D; Couvreur P
J Control Release; 2007 Dec; 124(1-2):20-7. PubMed ID: 17878060
[TBL] [Abstract][Full Text] [Related]
10. Characterization of lipophilic gemcitabine prodrug-liposomal membrane interaction by differential scanning calorimetry.
Castelli F; Sarpietro MG; Ceruti M; Rocco F; Cattel L
Mol Pharm; 2006; 3(6):737-44. PubMed ID: 17140261
[TBL] [Abstract][Full Text] [Related]
11. Discovery of new hexagonal supramolecular nanostructures formed by squalenoylation of an anticancer nucleoside analogue.
Couvreur P; Reddy LH; Mangenot S; Poupaert JH; Desmaële D; Lepêtre-Mouelhi S; Pili B; Bourgaux C; Amenitsch H; Ollivon M
Small; 2008 Feb; 4(2):247-53. PubMed ID: 18247384
[TBL] [Abstract][Full Text] [Related]
12. Characterization of complexes formed in fully hydrated dispersions of dipalmitoyl derivatives of phosphatidylcholine and diacylglycerol.
Quinn PJ; Takahashi H; Hatta I
Biophys J; 1995 Apr; 68(4):1374-82. PubMed ID: 7787023
[TBL] [Abstract][Full Text] [Related]
13. Polymer prodrug nanoparticles based on naturally occurring isoprenoid for anticancer therapy.
Trung Bui D; Maksimenko A; Desmaële D; Harrisson S; Vauthier C; Couvreur P; Nicolas J
Biomacromolecules; 2013 Aug; 14(8):2837-47. PubMed ID: 23829862
[TBL] [Abstract][Full Text] [Related]
14. Interaction of short-fragmented DNA with dipalmitoylphosphatidylcholine bilayers in presence of zinc.
Uhríková D; Pullmannová P; Bastos M; Funari SS; Teixeira J
Gen Physiol Biophys; 2009 Jun; 28(2):146-59. PubMed ID: 19592711
[TBL] [Abstract][Full Text] [Related]
15. Local anesthetics induce interdigitation and thermotropic changes in dipalmitoylphosphatidylcholine bilayers.
Reddy ST; Shrivastava S; Chattopadhyay A
Chem Phys Lipids; 2018 Jan; 210():22-27. PubMed ID: 29275150
[TBL] [Abstract][Full Text] [Related]
16. Self-assembly of polyisoprenoyl gemcitabine conjugates: influence of supramolecular organization on their biological activity.
Lepeltier E; Bourgaux C; Maksimenko A; Meneau F; Rosilio V; Sliwinski E; Zouhiri F; Desmaële D; Couvreur P
Langmuir; 2014 Jun; 30(22):6348-57. PubMed ID: 24835925
[TBL] [Abstract][Full Text] [Related]
17. Transmembrane diffusion of gemcitabine by a nanoparticulate squalenoyl prodrug: an original drug delivery pathway.
Bildstein L; Dubernet C; Marsaud V; Chacun H; Nicolas V; Gueutin C; Sarasin A; Bénech H; Lepêtre-Mouelhi S; Desmaële D; Couvreur P
J Control Release; 2010 Oct; 147(2):163-70. PubMed ID: 20691740
[TBL] [Abstract][Full Text] [Related]
18. Freeze-drying of squalenoylated nucleoside analogue nanoparticles.
Bildstein L; Hillaireau H; Desmaële D; Lepêtre-Mouelhi S; Dubernet C; Couvreur P
Int J Pharm; 2009 Nov; 381(2):140-5. PubMed ID: 19782881
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of n-squalenoyl cytarabine and evaluation of its affinity with phospholipid bilayers and monolayers.
Sarpietro MG; Ottimo S; Giuffrida MC; Rocco F; Ceruti M; Castelli F
Int J Pharm; 2011 Mar; 406(1-2):69-77. PubMed ID: 21219999
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, crystallization, and biological evaluation of an orally active prodrug of gemcitabine.
Bender DM; Bao J; Dantzig AH; Diseroad WD; Law KL; Magnus NA; Peterson JA; Perkins EJ; Pu YJ; Reutzel-Edens SM; Remick DM; Starling JJ; Stephenson GA; Vaid RK; Zhang D; McCarthy JR
J Med Chem; 2009 Nov; 52(22):6958-61. PubMed ID: 19860433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
